机译:对基于羟肟酸的组蛋白脱乙酰酶抑制剂的结构洞察力抗癌活性
Medicinal Chemistry Research Laboratory SLT Institute of Pharmaceutical Sciences Guru Ghasidas;
Medicinal Chemistry Research Laboratory SLT Institute of Pharmaceutical Sciences Guru Ghasidas;
Medicinal Chemistry Research Laboratory SLT Institute of Pharmaceutical Sciences Guru Ghasidas;
Medicinal Chemistry Research Laboratory SLT Institute of Pharmaceutical Sciences Guru Ghasidas;
Medicinal Chemistry Research Laboratory SLT Institute of Pharmaceutical Sciences Guru Ghasidas;
Faculty of Pharmacy AIMST University Semeling 08100 Bedong Kedah Darul Aman Malaysia;
Institute of Pharmaceutical Sciences Kurukshetra University Kurukshetra-136 119 (Haryana) India;
Institute of Life Sciences Bhubaneswar-751 001 (Orissa) India;
Institute of Pharmaceutical Sciences and Research GLA University Mathura-281 406 (UP) India;
Anticancer agents; Belinostat; Givinostat; Histone; Histone deacetylase inhibitors; Hydroxamic acid; Panobinostat; Vorinostat;
机译:对基于羟肟酸的组蛋白脱乙酰酶抑制剂的结构洞察力抗癌活性
机译:吡咯作为羟肟酸的组蛋白脱乙酰化酶抑制剂的连接单元评估:合成,抗癌评估和分子对接研究
机译:基于羟基乙酸的组蛋白十氢乙烯化抑制剂:作为抗癌剂的当前和未来前景
机译:HC-毒素羟肟酸类似物的合成及其对组蛋白脱乙酰酶的抑制活性
机译:组蛋白脱乙酰基酶(HDAC)抑制剂的结构要求:在C3,C6和C7位置修饰的Suberoylanilide异羟肟酸(SAHA)类似物可提高选择性
机译:组蛋白脱乙酰化酶抑制剂的结构要求:在C6位置改性的Suberoylanilide异羟肟酸类似物
机译:MHY218新型羟肟酸衍生的组蛋白脱乙酰酶抑制剂在人卵巢癌细胞中的抗癌作用